<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Huang M</submitter><pubmed_abstract>Qi-Yu-San-Long decoction (QYSLD), a traditional Chinese medicine (TCM) prescription, consisting of ten types of herbal medicine which has significant clinical efficacy in the treatment of non-small cell lung cancer (NSCLC). However, the bioactive ingredients of QYSLD remain unclear, due to their "multi-ingredients" and "multi-targets" features. This study aimed to construct a spectrum-effect correlation analysis model and screen the potential active components of QYSLD. A fingerprint method based on ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS) was developed and validated to obtain seventy common peaks of ten batches of QYSLD. The results of methodological evaluation, including precision, repeatability and stability, were less than</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>989139</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9627220</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Discovering the potential active ingredients of Qi-Yu-San-Long decoction for anti-oxidation, inhibition of non-small cell lung cancer based on the spectrum-effect relationship combined with chemometric methods.</pubmed_title><pmcid>PMC9627220</pmcid><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Zhou A</pubmed_authors><pubmed_authors>Yang M</pubmed_authors><pubmed_authors>Huang M</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Wu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovering the potential active ingredients of Qi-Yu-San-Long decoction for anti-oxidation, inhibition of non-small cell lung cancer based on the spectrum-effect relationship combined with chemometric methods.</name><description>Qi-Yu-San-Long decoction (QYSLD), a traditional Chinese medicine (TCM) prescription, consisting of ten types of herbal medicine which has significant clinical efficacy in the treatment of non-small cell lung cancer (NSCLC). However, the bioactive ingredients of QYSLD remain unclear, due to their "multi-ingredients" and "multi-targets" features. This study aimed to construct a spectrum-effect correlation analysis model and screen the potential active components of QYSLD. A fingerprint method based on ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS) was developed and validated to obtain seventy common peaks of ten batches of QYSLD. The results of methodological evaluation, including precision, repeatability and stability, were less than</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-03T22:22:54.03Z</modification><creation>2025-02-19T00:31:52.044Z</creation></dates><accession>S-EPMC9627220</accession><cross_references><pubmed>36339563</pubmed><doi>10.3389/fphar.2022.989139</doi></cross_references></HashMap>